Patent ID: 8778400

Claim:
A nanoparticle-stabilised capsule formulation comprising a discontinuous phase comprising droplets comprising: an oil-based or lipidic medium carrier selected from the group consisting of: triglyceride oils (medium or long-chained), soyabean oil, sunflower oil and almond oil, an anti-inflammatory agent selected from the group consisting of celecoxib and indomethacin, and an emulsifier selected from the group consisting of lecithin and oleylamine, wherein the anti-inflammatory agent is present in the discontinuous phase at a concentration in the range of 0.01 to 10 wt. %, wherein said droplets are stabilised with nanoparticles coated on the surface of the droplets, and wherein the nanoparticles are selected from the group consisting of silica nanoparticles, titania nanoparticles and latex nanoparticles.